Found 10 results
↓ CSVName | Type of Offering | Accepted Date |
---|---|---|
Amylyx Pharmaceuticals, Inc.
See All Filings
|
D/A | 2020-01-28 16:51:19 |
Amount To Be Raised
$20,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001658551
Filed Document
0001658551-20-000001
Exclusions or Exemptions
506b
Accepted Date
2020-01-28 16:51:19
Type of Offering
D/A
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
MASSACHUSETTS
Revenue or Assets
Decline to Disclose
Type of Security
Debt
|
||
Amylyx Pharmaceuticals, Inc.
See All Filings
|
D | 2019-12-31 10:21:59 |
Amount To Be Raised
$15,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001658551
Filed Document
0001658551-19-000001
Exclusions or Exemptions
506b
Accepted Date
2019-12-31 10:21:59
Type of Offering
D
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
MASSACHUSETTS
Revenue or Assets
Decline to Disclose
Type of Security
Debt
|
||
Amylyx Pharmaceuticals, Inc.
See All Filings
|
D/A | 2015-11-20 |
Amount To Be Raised
$1,630,000
Associated Brokers / Dealers
N/A
CIK Number
0001658551
Filed Document
0001658551-15-000002
Exclusions or Exemptions
506c
Accepted Date
2015-11-20
Type of Offering
D/A
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
MASSACHUSETTS
Revenue or Assets
Decline to Disclose
Type of Security
Debt
|
||
Amylyx Pharmaceuticals, Inc.
See All Filings
|
D/A | 2019-12-31 11:20:46 |
Amount To Be Raised
$15,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001658551
Filed Document
0001658551-19-000003
Exclusions or Exemptions
506b
Accepted Date
2019-12-31 11:20:46
Type of Offering
D/A
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
MASSACHUSETTS
Revenue or Assets
Decline to Disclose
Type of Security
Debt
|
||
Amylyx Pharmaceuticals, Inc.
See All Filings
|
D | 2015-11-17 |
Amount To Be Raised
$1,630,000
Associated Brokers / Dealers
N/A
CIK Number
0001658551
Filed Document
0001658551-15-000001
Exclusions or Exemptions
506c
Accepted Date
2015-11-17
Type of Offering
D
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
MASSACHUSETTS
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Amylyx Pharmaceuticals, Inc.
See All Filings
|
D/A | 2016-08-22 10:23:34 |
Amount To Be Raised
$5,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001658551
Filed Document
0001658551-16-000004
Exclusions or Exemptions
506b
Accepted Date
2016-08-22 10:23:34
Type of Offering
D/A
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
MASSACHUSETTS
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Amylyx Pharmaceuticals, Inc.
See All Filings
|
D | 2018-11-20 12:04:30 |
Amount To Be Raised
$12,978,100
Associated Brokers / Dealers
N/A
CIK Number
0001658551
Filed Document
0001658551-18-000001
Exclusions or Exemptions
506b
Accepted Date
2018-11-20 12:04:30
Type of Offering
D
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
MASSACHUSETTS
Revenue or Assets
Decline to Disclose
Type of Security
Debt
|
||
Amylyx Pharmaceuticals, Inc.
See All Filings
|
D | 2016-08-22 10:01:10 |
Amount To Be Raised
$5,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001658551
Filed Document
0001658551-16-000003
Exclusions or Exemptions
506b
Accepted Date
2016-08-22 10:01:10
Type of Offering
D
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
MASSACHUSETTS
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Amylyx Pharmaceuticals, Inc.
See All Filings
|
D | 2017-08-04 12:43:33 |
Amount To Be Raised
$2,342,698
Associated Brokers / Dealers
N/A
CIK Number
0001658551
Filed Document
0001658551-17-000001
Exclusions or Exemptions
506b
Accepted Date
2017-08-04 12:43:33
Type of Offering
D
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
MASSACHUSETTS
Revenue or Assets
Decline to Disclose
Type of Security
Debt
|
||
Amylyx Pharmaceuticals, Inc.
See All Filings
|
D | 2020-07-01 10:57:05 |
Amount To Be Raised
$30,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001658551
Filed Document
0001658551-20-000002
Exclusions or Exemptions
506b
Accepted Date
2020-07-01 10:57:05
Type of Offering
D
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
MASSACHUSETTS
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|